Literature DB >> 25968285

Non-cystic fibrosis bronchiectasis: clinical presentation, diagnosis and treatment, illustrated by data from a Dutch Teaching Hospital.

J Altenburg1, K Wortel, T S van der Werf, W G Boersma.   

Abstract

This review article describes the epidemiology, clinical presentation, diagnostic workup and treatment options in adult non-cystic fibrosis (non-CF) bronchiectasis (widening of mainly small and medium-sized bronchi as seen on chest computed tomography (CT) scan). We illustrate evidence from the literature with our own data retrieved from chart review, involving 236 adult patients with recurrent lower respiratory tract infections and high-resolution CT-proven non-CF bronchiectasis, who visited the outpatient clinic for respiratory diseases of a large Dutch teaching hospital between 2000 and 2010. Non-CF bronchiectasis can be described as a final common pathway of a vicious cycle of excessive bronchial inflammation, bacterial colonisation and infection. Non-CF bronchiectasis may arise from several causes, headed by infection and immunodeficiency, and is clinically characterised by a chronic, productive cough and infectious exacerbations. Once non-CF bronchiectasis is diagnosed using high-resolution CT scanning, a protocol-driven work-up to identify the underlying cause is recommended. Non-medicinal treatment options are primarily directed at clearance of bronchial secretions, which can further be improved by inhalation of hyperosmolar agents. Antibiotic treatment of exacerbations is a cornerstone medicinal treatment in bronchiectasis management. Patients with frequent exacerbations can be considered for long-term low-dose macrolide treatment, supported by robust evidence. Inhaled antibiotics might be beneficial in selected patients colonised with Pseudomonas aeruginosa. Important developments in the last decade include the introduction of international guidelines and the proposal for a validated scoring system for disease severity. Bronchiectasis patients are encountered by physicians in diverse medical professions and the disease itself is still underdiagnosed. The authors aim to increase awareness of the condition and provide practical tools for diagnosis and treatment.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25968285

Source DB:  PubMed          Journal:  Neth J Med        ISSN: 0300-2977            Impact factor:   1.422


  7 in total

1.  The Primary Ciliary Dyskinesia Computed Tomography Score in Adults with Bronchiectasis: A Derivation und Validation Study.

Authors:  Jessica Rademacher; Sabine Dettmer; Jan Fuge; Jens Vogel-Claussen; Hoen-Oh Shin; Anand Shah; Paula Inês Pedro; Rob Wilson; Tobias Welte; Frank Wacker; Michael R Loebinger; Felix C Ringshausen
Journal:  Respiration       Date:  2021-04-23       Impact factor: 3.580

2.  Editorial: Chronic Suppurative Lung Disease and Bronchiectasis in Children and Adolescents.

Authors:  Kah Peng Eg; Virginia Mirra; Anne B Chang; Francesca Santamaria
Journal:  Front Pediatr       Date:  2017-09-05       Impact factor: 3.418

Review 3.  Suspecting non-cystic fibrosis bronchiectasis: What the busy primary care clinician needs to know.

Authors:  Diego J Maselli; Bravein Amalakuhan; Holly Keyt; Alejandro A Diaz
Journal:  Int J Clin Pract       Date:  2017-02       Impact factor: 2.503

4.  Computed tomography in adult patients with primary ciliary dyskinesia: Typical imaging findings.

Authors:  Sabine Dettmer; Felix Ringshausen; Jens Vogel-Claussen; Jan Fuge; Amir Faschkami; Hoen-Oh Shin; Nicolaus Schwerk; Tobias Welte; Frank Wacker; Jessica Rademacher
Journal:  PLoS One       Date:  2018-02-06       Impact factor: 3.240

5.  Functional impairment in bronchiectasis: Spirometry parameters versus St. George's Respiratory Questionnaire scores: Any co-relation?

Authors:  Priyanka Singh; C D S Katoch; Vasu Vardhan; Manu Chopra; Sarvinder Singh; Nitin Ahuja
Journal:  Lung India       Date:  2021 Nov-Dec

6.  Azithromycin or erythromycin? Macrolides for non-cystic fibrosis bronchiectasis in adults: A systematic review and adjusted indirect treatment comparison.

Authors:  Wen Li; Zhong Qin; Jie Gao; Zhibin Jiang; Yihui Chai; Liancheng Guan; Yunzhi Chen
Journal:  Chron Respir Dis       Date:  2018-08-12       Impact factor: 2.444

7.  Allergic bronchopulmonary aspergillosis in patients with cystic fibrosis and non-cystic fibrosis bronchiectasis.

Authors:  Soheila Alyasin; Mozhgan Moghtaderi; Shirin Farjadian; Maryam Babaei; Saeed Hosseini Teshnizi
Journal:  Electron Physician       Date:  2018-01-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.